Welcome to Our Resource Library

The Modernization of Cosmetics Regulation Act of 2022 (MOCRA) overhauls the U.S. Food and Drug Administration’s (FDA) regulatory framework for cosmetics and expands its oversight over the industry... The Modernization of Cosmetics Regulation Act of 2022 (MOCRA) overhauls the U.S. Food and Drug Administration’s (FDA) regulatory framework for cosmetics and expands its oversight over the industry. The […]

The FDA’s “Substances Generally Recognized as Safe” Rule, better known as the GRAS Rule, is a lawful exercise of the FDA’s authority, according to a recent decision by the U.S. District Court for the Southern District of New York… The U.S. Food and Drug Administration’s (FDA) “Substances Generally Recognized as Safe” Rule, better known as […]

FDA recently sent an overdue report to Congress regarding its review of CBD products for mislabeling and adulteration… The U.S. Food and Drug Administration (FDA) recently sent an overdue report to Congress regarding its review of cannabidiol (CBD) products for mislabeling and adulteration. The FDA report revealed that mislabeling and adulteration are not widespread, it did […]

Curaleaf Holdings, One of the Largest Cannabis Companies in the U.S., Recently Found Itself on the Receiving End of a Stern Warning from the U.S. Food and Drug Administration (FDA)  Curaleaf Holdings (Curaleaf), one of the largest cannabis companies in the country, recently found itself on the receiving end of a stern warning from the […]

Mobile healthcare apps are big business. An estimated 500 million smartphone users worldwide will be using them by 2015. In response to the growing industry, the U.S. Food and Drug Administration (FDA) recently released its plan to regulate medical healthcare apps. The new rules will not impact tools that allow you to look up the […]